Standard BioTools
(NASDAQ) LAB
Standard BioTools Financials at a Glance
Market Cap
$373.69M
Revenue (TTM)
$85.33M
Net Income (TTM)
$74.90M
EPS (TTM)
$-0.20
P/E Ratio
-4.86
Dividend
$0.00
Beta (Volatility)
1.50 (High)
Dividend
$0.00
Beta (Volatility)
1.50 (High)
Price
$0.90
Volume
92,539
Open
$0.94
Price
$0.90
Volume
92,539
Open
$0.94
Previous Close
$0.90
Daily Range
$0.90 - $0.94
52-Week Range
$0.90 - $1.72
Dividend
$0.00
Beta (Volatility)
1.50 (High)
Price
$0.90
Volume
92,539
Open
$0.94
Previous Close
$0.90
Daily Range
$0.90 - $0.94
52-Week Range
$0.90 - $1.72
LAB News
Why Fluidigm Stock Plunged Today
Why Fluidigm Stock Surged Today
LAB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Standard BioTools
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
389
CEO
Michael Egholm, PhD
Website
www.standardbio.comHeadquarters
South San Francisco, CA 94080, US
LAB Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
-1%
Net Income Margin
-88%
Return on Equity
-14%
Return on Capital
-20%
Return on Assets
-13%
Earnings Yield
-20.58%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$373.69M
Shares Outstanding
390.07M
Volume
92.54K
Short Interest
0.00%
Avg. Volume
1.86M
Financials (TTM)
Gross Profit
$42.54M
Operating Income
$93.31M
EBITDA
$94.96M
Operating Cash Flow
$74.35M
Capital Expenditure
$8.30M
Free Cash Flow
$82.65M
Cash & ST Invst.
$187.57M
Total Debt
$30.83M
Standard BioTools Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.22M
-93.1%
Gross Profit
$2.69M
-87.7%
Gross Margin
83.49%
N/A
Market Cap
$373.69M
N/A
Market Cap/Employee
$459.08K
N/A
Employees
814
N/A
Net Income
$19.28M
+156.6%
EBITDA
$18.04M
+30.7%
Quarterly Fundamentals
Net Cash
$156.75M
-39.7%
Accounts Receivable
$13.43M
-60.0%
Inventory
$19.98M
-51.0%
Long Term Debt
$25.34M
-5.3%
Short Term Debt
$5.49M
-11.8%
Return on Assets
-13.19%
N/A
Return on Invested Capital
-20.31%
N/A
Free Cash Flow
$1.67M
+90.4%
Operating Cash Flow
$1.20M
+91.5%